Betta Pharmaceuticals Hits Day Low of CNY 57.88 Amid Price Pressure

Betta Pharmaceuticals Co., Ltd. experienced significant volatility on July 17, 2026, with the stock declining by 11.03% and reaching an intraday low of CNY 57.88. This performance starkly contrasts with the broader market, as the China Shanghai Composite index fell by only 3.05% on the same day. Over the past week, Betta Pharmaceuticals has seen a decline of 12.07%, while its one-year performance shows a decrease of 5.25%. However, the company has demonstrated a more favorable year-to-date performance, up 24.03%, despite a challenging overall market environment. Financial metrics reveal that Betta Pharmaceuticals has a market capitalization of CNY 20,232 million and a price-to-earnings ratio of 52.00. The company's return on equity stands at 5.72%, and it has a price-to-book ratio of 2.98, indicating a relatively high valuation. Additionally, the stock offers a dividend yield of 0.71%. Despite recent fluctuations, the company has shown a long-term growth rate in net sales of 15.17% over the past five years, although operating profit growth has been more modest at 9.21%.